GSK’s global supply chain is intricate, involving both primary (active pharmaceutical ingredients manufacturing) and secondary (finished product creation) locations. Therefore, the first challenge was ...
8d
Pharmaceutical Technology on MSNAmid deglobalising trade, experts seek AI safeguards for clinical trial supplyThe role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...
Businesses can now set science-based targets covering ocean and maritime protection, under the latest guidance introduced by ...
Here are the critical medicines in short supply in the EU, according to the latest available information from the EMA and ...
Pharmaceutical majors AstraZeneca and GSK have partnered with competitor Takeda and nine suppliers to accelerate the adoption ...
The 10 most undervalued stocks from our Best Companies to Own list as of Feb. 27, 2025, were: Here’s a little bit about why ...
The National Agency for Food and Drug Administration and Control (NAFDAC) destroyed expired, falsified, controlled, unregistered, and banned medicines worth ...
Breakthrough Adjuvant AB-801 Secures “Bioprocessing Excellence in Taiwan” HonorTAIPEI, Taiwan, March 13, 2025 (GLOBE NEWSWIRE ...
GSK has pledged to 100% use of renewable across the company by 2025, and an 80% reduction in carbon emissions by 2030 en route to net zero across all its supply chain – including purchased goods ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results